Clover Health Investments, Corp.
CLOV· Nasdaq
Released May 9, 2023, after the close
10-Q filed May 9, 2023, 39 days after period end · 0001801170-23-000038
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $321.99M | $874.38M | $200.33M | $165.51M |
| Net Income | -$72.61M | -$75.49M | -$48.42M | -$28.16M |
| EPS Diluted |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$0.15 |
| -$0.16 |
| -$0.13 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.